ATXI
Avenue Therapeutics Inc

5,445
Loading...
Loading...
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2

Frequently Asked Questions

What is Market Cap of Avenue Therapeutics Inc?
What is the 52-week high for Avenue Therapeutics Inc?
What is the 52-week low for Avenue Therapeutics Inc?
What is Avenue Therapeutics Inc stock price today?
What was Avenue Therapeutics Inc stock price yesterday?
What is the PE ratio of Avenue Therapeutics Inc?
What is the Price-to-Book ratio of Avenue Therapeutics Inc?
What is the 50-day moving average of Avenue Therapeutics Inc?
How many employess does Avenue Therapeutics Inc has?

Latest ATXI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.